Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

PLC Systems granted patent integral to Heart Laser technology

Aug. 16, 1996

Cardiac tropinin provides accurate detection of MI

Aug. 16, 1996

Zynaxis to develop Zyn-Linker form of heparin under SBIR grant

Aug. 16, 1996

Kanebo reports Na+/H+ exchange inhibitors

Aug. 16, 1996

Antihypertensive quinazoline derivatives described by Nippon Chemiphar

Aug. 16, 1996

American Cyanamid claims vasopressin antagonists

Aug. 16, 1996

More nitric oxide synthase inhibitors from Japan Tobacco

Aug. 9, 1996

Nitric oxide synthase inhibitors described by Hoechst

Aug. 9, 1996

FDA clears Mylan's nicardipine HCl

Aug. 9, 1996

UCB reports alpha-adrenergic ligands with cardiovascular activity

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...